The web site logo

Login My Account Help
 Search lipid.org

NELA Officer and Board of Director Nominations

The Nominating Committee recommends the following slate of candidates to serve in the Officer and available at-large Board member positions.

In accordance with the Bylaws of the Northeast Lipid Association, the office of the President and Immediate Past-President are not elected. The offices of the President-Elect, the Treasurer, and the Secretary are elected. If affirmed, these NELA members take their respective roles immediately following the NELA Annual Business Meeting.

2011-2012 Northeast Lipid Association Executive CommitteeThose Nominated to Serve in At-Large Direction Positions

President
Thomas N. Tulenko, PhD
Camden, NJ

President-Elect
Perry J. Weinstock, MD, FACC
Camden, NJ

Treasurer
James A. Underberg, MD
New York, NY

Secretary
Joyce Ross, MSN, CRNP
Philadelphia, PA

Immediate Past-President
Donald A. Smith, MD
New York, NY

Term Expiring 2013
Allan D. Sniderman, MD
Montreal, QB, Canada

Term Expiring 2014
Sidney Alexander, MD
Burlington, MA

Danielle Duffy, MD
Philadelphia, PA

Wahida Karmally, RD, DrPh, CDE
New York, NY

Kenneth A. Kellick, PharmD
Buffalo, NY

Spencer D. Kroll, MD
Morganville, NJ

Judith E. Schipper, MS, NP
New York, NY

Daniel E. Soffer, MD
Media, PA

See Sections 4.2 and 5.1 of the NELA Bylaws regarding nominations from the floor.

4.2 Election of Officers
(a) The President, President-Elect, Secretary, and Treasurer are elected for a term of one (1) year, or until successors are elected, by a majority vote of the members present at the Business Meeting. Following the Nominating Committee's report, nominations for Officers may also be made from the floor of the Annual Meeting provided that a petition, signed by at least ten (10) active members in support of each nominee, has been received by the Board of Directors at least thirty (30) days prior to the Business Meeting.
(b) All Officers shall immediately assume their respective offices and the President-Elect shall automatically succeed to President at the end of the Business Meeting

5.1 Election of the Board of Directors
(a) The Board of Directors shall consist of a maximum of twenty-nine (29) members including the President, President-Elect, Secretary, Treasurer, Immediate Past-President, and general Board members.
(b) Excluding the Officers, valid nominations for at large positions on the Board shall include the recommendations of the Nominating Committee and nominations from the floor of the Business Meeting, provided that a petition signed by ten (10) members in support of each floor nominee has been submitted to the Board of Directors at least thirty (30) days prior to the Annual Meeting.

Nominating Committee Members
Penny Kris-Etherton, PhD, RD - Chair
David Capuzzi, MD, PhD
Jeffrey Freeman, DO
Dean Karalis, MD
Donald Smith, MD
Thomas Tulenko, PhD

We would like to thank the following NLA members for their service to the NELA Board of Directors:
Ira Goldberg, MD, New York, NY
Janet Long, MSN, ACNP, Providence, RI
John M. Morgan, MD, Wynnewood, PA


FH Awareness


code-red ACCL New! HDL CVD ABCL 100QA 100QA

100QA code-red ACCL New! HDL CVD ABCL 100QA

2012